MedPath

Does increasing lean red meat intake impact iron status in physically-active women?

Not Applicable
Conditions
Iron deficiency without anemia
Nutritional, Metabolic, Endocrine
Registration Number
ISRCTN43345245
Lead Sponsor
Dublin City University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Ongoing
Sex
Female
Target Recruitment
48
Inclusion Criteria

Phase I
1. Female;
2. Aged 18 to 40 years;
3. Physically active defined as currently active for not less than 4 exercise sessions per week lasting more than 30 minutes each at high intensity, or more than 60 minutes at moderate intensity, or a combination thereof moderate and high intensity sessions;

Phase II
4. Participants fulfilling the inclusion criteria for status as iron deficient without anaemia i.e. a haemoglobin concentration not less than 12.0 g/dL i.e. non-anaemic, and either serum ferritin = or more than 12 and <35µg/L, or transferrin saturation <16%, or both, combined with habitual dietary iron intake of less than the current estimated average requirement (EAR) i.e. <11.4 mg/day, will be eligible to move forward into Phase II.

Exclusion Criteria

1. Male;
2. Individuals under the age of 18 and over 40 years of age;
3. Individuals with normal iron status (Ferritin >35 µg/L and haemoglobin = or more than 12 g/dL); Individuals with anaemia (haemoglobin <12 g/dL for females);
4. Individuals who present with neuromuscular, chronic, and metabolic diseases and carriers of high-risk blood-borne diseases;
5. Individuals currently on an energy-restricted diet;
6. Individuals currently supplementing with iron or vitamin C supplements;
7. Individuals currently practising a dietary restriction as vegetarian, vegan, ketogenic or Low carbohydrate diet (defined as CHO intake of <130 g/day);
8. Habitual dietary iron intake in accordance to the current estimated average requirement (EAR) i.e. = or more than 11.4 mg/day

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath